Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development

Area of Science:

• Ophthalmology
• Translational Medicine
• Preclinical Research

Background:

• Preclinical models are vital for studying human disease etiology, pathology, and progression.
• Ideal models replicate anatomical features, pathophysiological mechanisms, and disease progression patterns.
• Animal models for ophthalmological diseases aid in understanding pathogenesis and developing treatments.

Purpose of the Study:

• To review preclinical animal models used in developing new therapies for eye diseases.
• To summarize models critical for drug development and establish preclinical proof of concept (POC).
• To describe translational features of these models.

Main Methods:

• Literature review of preclinical animal models for ocular diseases.
• Focus on models relevant to new drug development.
• Analysis of translational features and their contribution to understanding disease and POC.

Main Results:

• Identified and summarized key preclinical models for ocular surface diseases, glaucoma, presbyopia, and retinal diseases (diabetic retinopathy, AMD).
• Highlighted the role of these models in understanding disease pathogenesis.
• Demonstrated the utility of models in establishing preclinical proof of concept for new therapies.

Conclusions:

• Preclinical animal models are indispensable tools in ophthalmology for advancing therapeutic development.
• These models facilitate a deeper understanding of disease mechanisms and provide a platform for evaluating treatment efficacy.
• The reviewed models are critical for bridging the gap between basic research and clinical application in eye care.